
Tetrahedron Letters p. 6657 - 6660 (1997)
Update date:2022-08-03
Topics:
Madec, David
Ferezou, Jean-Pierre
(E)-1-(tert-Butyldimethyl)silyloxy-3,3-bis(tributylstannyl)propene 11 as well as 1-N,N-diisopropylcarbamoyloxy-3,3-bis(tributylstannyl)propene 10 have been prepared upon addition of Bu3Sn(Bu)Cu(CN)Li2 8 to diverse γ-heterosubstituted acrolein precursors, followed by addition of excess HMPA and of the required electrophile. A E/Z ratio of 95:5 was reached in the case of 11. The reaction may occur through an addition-elimination-addition sequence where the stannylated acrolein B is thought to be a common intermediate. The best results were obtained upon single conjugate addition of 8 to (E)-3-(tributylstannyl)-2-propenal 12 (78%). A two-pot synthesis of the title compound was developed from the inexpensive malonaldehyde bis(dimethyl)acetal 14.
View MoreSuzhou Health Chemicals Co., Ltd.
website:http://www.healthchems.com
Contact:13776257979
Address:No. 338, Jingang Avenue,
HEZE KINGVOLT CHEMICAL CO., LTD
Contact:86-573-82118911
Address:Juancheng Industry Park
Shenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Anhui New Star Pharmaceutical Development Co., Ltd
Contact:013956922763
Address:Floor 3, F9A, F Workshop, No.110 Kexue Road, High-Tech Development Zone, Hefei, Anhui ,China
HENAN NEW BLUE CHEMICAL CO.,LTD
website:http://www.newbluechem.com
Contact:86-371-55170693/55170694
Address:Zhengzhou International Trade New Territory,Jinshui District,Zhengzhou ,China
Doi:10.1002/ejoc.201701567
(2018)Doi:10.1021/jo01068a082
(1961)Doi:10.1016/j.tetlet.2017.02.085
(2017)Doi:10.1002/hlca.19980810511
(1998)Doi:10.1248/cpb.30.569
(1982)Doi:10.1039/c39790001102
(1979)